Which of the following statements about the electron transport chain is CORRECT?
The mechanism by which cytosolic pyruvate is transported to mitochondria is
The citric acid cycle is a hub of energy transformation. Which citric acid cycle enzyme produces ATP by substrate-level phosphorylation?
Final common pathway of metabolism of carbohydrate, lipids, and protein metabolism is?
Hyperammonemia impairs the citric acid cycle by depleting which of the following?
Which molecule serves as the primary acceptor for acetyl-CoA to initiate the TCA cycle?
In a patient who has been in a state of starvation for 72 hours, which of the following is the primary mechanism for maintaining blood glucose levels?
H2S inhibits which complex of the electron transport chain?
What is the number of ATP produced by red blood cells (RBC) during glycolysis when utilizing the Rapoport-Luebering pathway?
All of the following are inhibitors of cytochrome oxidase, except:
Explanation: ***FADH2 gives 1.5 ATP*** - Each **FADH2** molecule that enters the electron transport chain generates approximately **1.5 ATP molecules** via oxidative phosphorylation based on modern P/O ratio calculations. - FADH2 bypasses Complex I and enters at **Complex II (succinate dehydrogenase)**, thus contributing to fewer proton pumping sites (only Complexes III and IV) compared to NADH. - This is the modern, accurate value based on current understanding of mitochondrial bioenergetics. *NADH enters at Complex I* - While this statement is **factually true**, NADH entering at Complex I is well-established biochemistry. - However, when combined with the context of other options, **option C provides the most clinically relevant quantitative information** about ATP yield. - NADH oxidation at Complex I pumps protons at three sites (Complexes I, III, and IV). *FADH2 enters at Complex II* - This statement is also **factually correct** - FADH2 does enter the electron transport chain at Complex II. - However, without mentioning the ATP yield, this statement is less complete than option C which provides quantitative information. *NADH gives 3 ATP* - This is **INCORRECT** based on modern biochemistry. - The current accepted value is approximately **2.5 ATP** per NADH molecule. - The older estimate of 3 ATP was based on integer P/O ratios that didn't account for the energy cost of ATP/ADP translocase and phosphate transporter.
Explanation: ***Proton symport*** - Pyruvate is transported into the mitochondrial matrix by the **mitochondrial pyruvate carrier (MPC)**, which functions as a **proton symporter**. - This transport mechanism couples the movement of pyruvate with the movement of a proton down its electrochemical gradient. *Chloride antiport (specific for chloride ions)* - **Chloride antiport** involves the movement of chloride ions in the opposite direction to another molecule, which is not the mechanism for pyruvate transport. - This mechanism is typically involved in maintaining **ionic balance** or specific solute transport across membranes, distinct from pyruvate uptake. *Facilitated uniport (passive transport)* - While pyruvate transport is a form of facilitated diffusion, it is specifically a **symport** mechanism, not a simple uniport. - **Uniport** involves the transport of a single solute down its concentration gradient without coupling to another molecule or ion. *ATP-dependent transport* - Pyruvate transport into the mitochondrion is **not directly ATP-dependent**; it utilizes the proton gradient rather than ATP hydrolysis. - **ATP-dependent transport** involves energy derived directly from ATP hydrolysis to move molecules against their concentration gradient.
Explanation: ***Succinate thiokinase*** - This enzyme (also known as **succinyl-CoA synthetase**) catalyzes the conversion of **succinyl-CoA** to **succinate**. - During this reaction, the energy released from the thioester bond of succinyl-CoA is used to directly phosphorylate ADP to **ATP** (or GDP to GTP), a classic example of **substrate-level phosphorylation**. *Succinate dehydrogenase* - This enzyme is part of both the **citric acid cycle** and the **electron transport chain** (Complex II). - It catalyzes the oxidation of **succinate to fumarate** and reduces FAD to **FADH2**, which then donates electrons to the electron transport chain, but it does not produce ATP directly. *Isocitrate dehydrogenase* - Catalyzes the oxidative decarboxylation of **isocitrate to α-ketoglutarate**, producing **NADH** and **CO2**. - The NADH generated contributes to ATP production through oxidative phosphorylation, not substrate-level phosphorylation. *Aconitase* - Catalyzes the reversible isomerization of **citrate to isocitrate**, with **cis-aconitate** as an intermediate. - This enzyme rearranges the molecule for subsequent oxidative steps but does not directly produce ATP or reduce coenzymes.
Explanation: ***TCA (Tricarboxylic Acid Cycle)*** - The **TCA cycle** (also called Krebs cycle or citric acid cycle) is the **final common oxidative pathway** where all three macronutrients converge - **Carbohydrates** → Pyruvate → **Acetyl-CoA** (via pyruvate dehydrogenase) - **Lipids** → Fatty acids → **Acetyl-CoA** (via beta-oxidation) - **Proteins** → Amino acids → **Acetyl-CoA or TCA intermediates** (via deamination/transamination) - Complete oxidation of acetyl-CoA occurs in the TCA cycle, producing **NADH, FADH2, and GTP** for energy production *Gluconeogenesis* - This is a **biosynthetic pathway** that synthesizes glucose from non-carbohydrate precursors (lactate, glycerol, amino acids) - It is an **anabolic process**, not the catabolic final common pathway for energy production from all macronutrients *Glycolysis* - **Carbohydrate-specific pathway** that converts glucose to pyruvate - It is only the initial breakdown pathway for carbohydrates, not the common pathway where lipids and proteins also converge - Pyruvate from glycolysis must enter TCA cycle for complete oxidation *HMP pathway (Pentose Phosphate Pathway)* - Parallel pathway to glycolysis that generates **NADPH** (for biosynthesis and antioxidant defense) and **ribose-5-phosphate** (for nucleotide synthesis) - Processes only **glucose-6-phosphate** from carbohydrate metabolism - Not involved in lipid or protein metabolism integration
Explanation: ***α-ketoglutarate*** - Excess ammonia in the brain reacts with **α-ketoglutarate** via **glutamate dehydrogenase** to form glutamate, and glutamate then converts to glutamine. - This depletion of α-ketoglutarate reduces the availability of a crucial citric acid cycle intermediate, thereby impairing the cycle's function and **ATP production**. *Pyruvate* - **Pyruvate** is primarily involved in the entry into the citric acid cycle via its conversion to acetyl-CoA, but hyperammonemia does not directly deplete it. - Ammonia metabolism primarily affects the glutamate-glutamine pathway, which consumes α-ketoglutarate, not pyruvate. *Oxaloacetate* - **Oxaloacetate** is a citric acid cycle intermediate, but its direct depletion is not the primary mechanism by which hyperammonemia impairs the cycle. - While cycle impairment may indirectly affect oxaloacetate levels, the direct consumption of **α-ketoglutarate** is the more immediate impact of hyperammonemia. *Succinate* - **Succinate** is an intermediate of the citric acid cycle and its levels would be affected by a general impairment, but it is not directly consumed by ammonia detoxification. - The primary target for ammonia in this context is **α-ketoglutarate** due to its role in glutamate synthesis.
Explanation: ***Oxaloacetate*** - **Oxaloacetate** is the **4-carbon acceptor molecule** that condenses with acetyl-CoA to form citrate, initiating each turn of the TCA cycle. - It acts as a **catalytic molecule** that is regenerated at the end of the cycle, allowing continuous operation. - Without oxaloacetate, acetyl-CoA cannot enter the cycle, making it the **rate-limiting requirement** for cycle initiation. *Acetyl-CoA* - Acetyl-CoA is the **2-carbon substrate** that enters the TCA cycle by combining with oxaloacetate. - While essential for providing carbons to be oxidized, it is not the acceptor molecule; rather, it is the molecule being accepted. *Citrate* - Citrate is the **6-carbon product** formed when acetyl-CoA condenses with oxaloacetate in the first reaction of the TCA cycle. - It is an intermediate product, not the acceptor molecule needed to initiate the cycle. *ATP* - ATP is an **energy product** of cellular respiration and acts as an **allosteric inhibitor** of the TCA cycle. - It does not serve as a substrate or acceptor molecule in the cycle's reactions.
Explanation: ***Increased gluconeogenesis*** - After 72 hours of starvation, **hepatic glycogen stores** are completely depleted, making gluconeogenesis the primary and essential mechanism to maintain **blood glucose levels**. - This process synthesizes glucose from non-carbohydrate precursors like **amino acids** (mainly alanine and glutamine), **lactate**, and **glycerol** to supply glucose for obligate glucose-dependent tissues like **red blood cells** and the **renal medulla**, and provides baseline glucose for the brain. - Gluconeogenesis occurs primarily in the **liver** and to a lesser extent in the **kidney cortex** during prolonged fasting. *Increased protein degradation* - While **protein degradation** does occur to supply amino acids for gluconeogenesis, the body actively minimizes this to preserve muscle mass, especially after prolonged starvation. - The initial phase of starvation (first 24-48 hours) sees more significant protein breakdown, but its rate decreases substantially after 72 hours as the body becomes increasingly **protein-sparing** and shifts to fatty acid oxidation and ketone body production. *Increased glycogenolysis* - **Hepatic glycogen stores** are typically depleted within **12-24 hours** of starvation. - After 72 hours, there is essentially no glycogen remaining to break down, so **glycogenolysis** cannot contribute to maintaining blood glucose at this stage. *Increased ketosis due to breakdown of fats* - **Ketosis** does dramatically increase after 72 hours of starvation as the body shifts to using **fatty acids** for energy and producing **ketone bodies** (β-hydroxybutyrate and acetoacetate) for the brain and other tissues. - However, while ketone bodies serve as an alternative fuel source for the brain (providing up to 60-70% of its energy needs), they **cannot replace glucose entirely** because certain tissues (red blood cells, renal medulla) are obligate glucose users and cannot utilize ketones. - The question specifically asks about maintaining **blood glucose levels**, which requires gluconeogenesis, not ketone production.
Explanation: ***Complex IV*** - Hydrogen sulfide (**H2S**) acts as a potent inhibitor of **cytochrome c oxidase** (**Complex IV**), interrupting the transfer of electrons to oxygen. - This inhibition prevents the final step of the electron transport chain, significantly impairing **ATP production** and leading to cellular anoxia. *Complex I* - **Complex I** (NADH dehydrogenase) is primarily inhibited by compounds such as **rotenone** and **barbiturates**, not H2S. - Inhibition of Complex I blocks the entry of electrons from **NADH** into the electron transport chain. *Complex II* - **Complex II** (succinate dehydrogenase) is primarily inhibited by **malonate**, which competes with succinate. - This complex accepts electrons directly from **FADH2** produced during the Krebs cycle, bypassing complex I. *Complex III* - **Complex III** (ubiquinone-cytochrome c reductase) is inhibited by drugs like **antimycin A**. - Inhibition at this complex prevents the transfer of electrons from **ubiquinol** to **cytochrome c**.
Explanation: ***Correct Option: 1*** - The Rapoport-Luebering pathway (2,3-BPG shunt) bypasses the **phosphoglycerate kinase** step in glycolysis - This bypass sacrifices **1 ATP molecule** that would normally be generated at this step - Normal glycolysis produces a net of 2 ATP per glucose (4 ATP produced - 2 ATP consumed) - With the Rapoport-Luebering shunt active, one of the two 1,3-bisphosphoglycerate molecules is diverted through the shunt - This reduces the total ATP yield from 4 to 3 in the payoff phase - **Net yield: 3 ATP (payoff) - 2 ATP (investment) = 1 ATP per glucose** *Incorrect Option: 2* - This represents the net ATP yield from **normal glycolysis without** the Rapoport-Luebering pathway - When the 2,3-BPG shunt is active, ATP production is reduced by one molecule - This option would be correct if the question asked about standard glycolysis *Incorrect Option: 6* - This value vastly exceeds the actual ATP production in RBC glycolysis - Even normal glycolysis (without any shunt) only yields a net of 2 ATP, not 6 - This may represent a confusion with ATP production from other metabolic pathways *Incorrect Option: 8* - This number is significantly higher than any ATP yield from glycolysis alone - The maximum theoretical net ATP from glycolysis is only 2 ATP under normal conditions - This option has no basis in the biochemistry of RBC glucose metabolism *Incorrect Option: 0* - While the Rapoport-Luebering pathway reduces ATP production, it does not eliminate it completely - The **pyruvate kinase** step still generates 2 ATP molecules (one from each of the two phosphoenolpyruvate molecules) - Even with one ATP lost to the shunt, the net yield remains positive at 1 ATP
Explanation: ***Amytal*** - **Amytal** (amobarbital) is a barbiturate that inhibits **Complex I** (NADH dehydrogenase) of the **electron transport chain**, not cytochrome oxidase (Complex IV). - Its mechanism involves binding to the flavoprotein site of Complex I, thereby blocking the transfer of electrons from **NADH** to ubiquinone. *Carbon monoxide* - **Carbon monoxide** is a potent inhibitor of **cytochrome oxidase (Complex IV)** by binding to the heme iron with very high affinity, preventing oxygen from doing so. - This effectively stops the final step of the electron transport chain, leading to **cellular anoxia**. *Cyanide* - **Cyanide** is a classic inhibitor of **cytochrome oxidase (Complex IV)**, forming a stable complex with the ferric iron (Fe3+) in the heme a3 of the cytochrome c oxidase enzyme. - This binding blocks the transfer of electrons to oxygen, halting **aerobic respiration**. *Azide* - **Azide** (as in sodium azide) is another powerful inhibitor of **cytochrome oxidase (Complex IV)**, similar to cyanide and carbon monoxide. - It binds to the heme iron in the active site of the enzyme, thereby preventing the reduction of oxygen to water and stopping cellular energy production.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free